“Pharma Poland News is the leading one among similar publications available on the market covering Polish pharmaceutical sector. This is why I decided to buy it. I like a division into weekly newsletter comprising short news, and monthly publication comprising analytical, in-depth articles with nice graphics. Another advantage is English language so there is no need to translate it for headquarters or foreign employees of the company.”PR manager, Teva Polska
“Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the strong experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. We consider PMR Ltd. a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend that company as a reliable partner in providing economic information and market analysis.”General Manager, Sanofi-Synthelabo
“I have been reading Pharma Poland News of PMR Publications, on a regular basis for aprox. 2 years.
It is a valuable source of information with comments and analysis on Polish and CEE pharmaceutical markets.
Pharma Poland News is an up-to-date, comprehensive and reliable publication which I find useful as the Country Head of Schering AG in Poland. It can be, therefore, reccomended to pharma profesionals, for its quality and accuracy of information presented.”President, Schering Polska Sp. z o.o.
“As a Germany company doing business in Poland, we really appreciate the reliable and useful information in Pharma Poland News. Especially the information of wholesalers, pharmaceutical law changes and announcement of new products registered in Poland are quite helpful to improve our business there.”Country Manager, Dr. Kade Pharmazeutische Fabrik GMBH
Stay up to date with the industry thanks to the Weekly News Briefings, and support you strategic decisions with the Monthly Reviews and Analysis issue.
The Pharma Poland News is a comprehensive source of information for pharmaceutical market professionals, especially executive staff, managers, marketing departments of medical, insurance or consulting companies, providers and distributors of medical supplies, investors, and financial and governmental institutions interested in the pharmaceutical market.
The newsletter is delivered in two parts:
weekly issue comprising mostly market, company, R&D and medical device news on the Polish pharma market, enhanced with Central Europe market briefing (major pharmaceutical events in Bulgaria, Czech Republic, Hungary, Romania and Slovakia)
Selection of vital market news, delivered straight to your email box
A set of carefully chosen pharmaceutical news will let you find out what is going on in the pharmaceutical market without time-consuming search on your own and verification of the sources’ reliability.
Thematic sections of the Pharma Poland News – Weekly News Briefing cover:
Market news - market size, trends, forecasts, legislative changes, healthcare policy, lists of reimbursed medicines, patient opinions and preferences
Company news - mergers and acquisitions, financial results, future plans concerning development, strategies, major investments, stock market debuts, new medicines to be introduced, new appointments
R&D / medical news - epidemiological data, prevention policies, legal changes, financial results, strategies, new openings, major collaborations in the Polish healthcare sector, major investments, statistical data.
Multi-angle expert market view, analyses and data
The monthly issue provides a wealth of analysis and data on the Polish pharmaceutical and healthcare market, enriched with articles on the European pharmaceutical market – as a whole, giving a solid comparative basis.
Articles are prepared by a number of market professionals cooperating with PMR, as well as our own pharma-dedicated analysts and editors, and concern:
monthly analyses of the pharmacy market in Poland – sales value and change by product category, reimbursement value and change, drug prices, pharmacy margins
analyses of changes on reimbursement lists in Poland
analyses of legal environment prepared by law consultancies
market segments analyses, e.g. private healthcare market, dentistry market, clinical trial market, dietary supplement market, medical device market, etc.
quarterly CEE pharmaceutical market analyses.
The Pharmaceutical data section within the Monthly Reviews and Analysis issue comprises new registrations of medicines, drug withdrawals, drug withholds, drug relaunches, bans on drug advertising.
In the Pharma Poland News, we put great emphasis on legal issues, which is a crucial aspect of operations for every pharmaceutical company. Therefore, the legal environment is a substantial part of the content – not only revealing vital news, but also providing legal experts’ interpretations of how it can impact operations of pharma firms.
Request more info/free trial
Pharma Poland News
1 year subscription: (52 issues of weekly news and 12 issues of monthly analysis)
"Single user licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
- for the product preservation: saving the product in the memory of one computer belonging to the client;
- for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
"5-user licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
- for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
"Corporate licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
- for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
"Global licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
- for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
- for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
PMR is a member of SIIA's Corporate Content Anti-Piracy Program. Breaking the conditions of our licences will result in a report being sent to SIIA to initiate a piracy investigation and major fees may be imposed by the SIIA as a result. Additionally, for newsletters and online services, it will result in suspension of the subscription with no money refund.
PMRis a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.
PMR Online Access
